Clinical Trials Logo

Body Weight Changes clinical trials

View clinical trials related to Body Weight Changes.

Filter by:

NCT ID: NCT02621814 Completed - Body Weight Changes Clinical Trials

Clinical Trial of Infant Formula-fed

Start date: May 6, 2016
Phase: N/A
Study type: Interventional

Compared with breast milk and another commercially available formula, infants' growth rate after 12 weeks' Friso formula with low glycation feeding will be assessed.

NCT ID: NCT02561754 Completed - Weight Loss Clinical Trials

Weight Management for Adolescents With IDD

IDDAdol
Start date: March 2015
Phase: N/A
Study type: Interventional

The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.

NCT ID: NCT02554318 Completed - Motor Activity Clinical Trials

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

FSS
Start date: November 2013
Phase: N/A
Study type: Interventional

Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.

NCT ID: NCT02388958 Completed - Clinical trials for Gestational Diabetes Mellitus

Weight Changes During and After Pregnancy in Women With Gestational Diabetes

Start date: June 2014
Phase: N/A
Study type: Observational

Gestational diabetes mellitus (GDM) is associated with short-term and long-term complications for infants and mothers. The management of GDM during pregnancy focuses on reducing risks to the infant associated with hyperglycemia. The postpartum management of GDM focuses on reducing maternal risk of developing type 2 diabetes (T2DM). A diagnosis of GDM identifies up to 31% of parous women who will eventually develop T2DM and approximately 50% of women diagnosed with GDM will develop T2DM in the first 5 years postpartum. The perceived risk of developing short-term and/or long-term complications of GDM may influence women's likelihood of engaging in diet modification, the mainstay of treatment of GDM, both during and after pregnancy. If sustained after delivery, diet modifications introduced as treatment for GDM could affect maternal weight changes during and after pregnancy, which could in turn affect T2DM risk. It is unknown if and how women with GDM differ in their perceived risk of developing T2DM, dietary choices, or weight gain (and retention) during versus after pregnancy. Therefore, the project proposed in this application seeks to (1) characterize the perceived risk of developing T2DM among women with GDM during and after pregnancy, (2) characterize dietary choices of women with GDM during and after pregnancy, and (3) characterize weight changes of women with GDM during and after pregnancy as compared to women without GDM.

NCT ID: NCT02229708 Completed - Obesity Clinical Trials

Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether a technology-base healthy lifestyle program is an acceptable and effective way for African-American mothers to improve their eating and activity during pregnancy, compared to usual obstetric care. The goal of the program is to enhance the health of African-American mothers and their babies.

NCT ID: NCT02063048 Completed - Prediabetes Clinical Trials

Text Messaging for Weight Loss

Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of text message-based support to usual care at promoting weight loss in patients with pre-diabetes.

NCT ID: NCT02052518 Completed - Body Weight Changes Clinical Trials

Early Childhood Obesity Prevention Program

ECHO
Start date: June 2013
Phase: N/A
Study type: Interventional

This study is proposed on behalf of the Hartford Childhood Wellness Alliance, a 107 member, 35 group organization whose goal is to improve the health of children in Hartford, CT. In a randomized control trial, the primary aim of this study is to test the initial efficacy of a program of enhanced home visitation with neighborhood and community support to change maternal behaviors related to infant nutrition (sweetened beverage/juice consumption, breastfeeding and introduction of solids), parenting skills (establishing routines around sleep, reading cues for hunger, satiety, television time) and family wellness (improving the home food environment, enhancing physical activity). The investigators hypothesize that at 12 months of age, infants in the intervention arm will drink less sugar sweetened beverages/juices, will have ingested solids at an older age, will have been breastfed longer and more exclusively than infants in the control arm and will have less TV viewing, more established sleep routines and greater soothability (primary outcomes).

NCT ID: NCT02035150 Completed - Obesity Clinical Trials

Effect of Different Fiber Breakfasts on Appetite and Weight Change in Overweight Subjects

Start date: March 1998
Phase: N/A
Study type: Interventional

Regular breakfast consumption may help lower body weight reduce body fatness and improve cardiovascular disease risk factors. However, the best kind of breakfast to consume to achieve these effects is unclear. We hypothesized that a high fiber breakfast would suppress appetite, lower body weight and improve cardiovascular disease risk factors compared with a no-fiber breakfast.

NCT ID: NCT02030353 Completed - Breast Neoplasms Clinical Trials

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility of two 6-month behavioral interventions for weight gain prevention (self-regulation plus activity monitoring or self-regulation) among African American breast cancer survivors along with a delayed control group. Participants will be 45 African American post-treatment breast cancer survivors. Intervention content will be delivered online with one face-to-face individual meeting. Weight, clinical and psychosocial measures will be assessed at baseline, 3 and 6 months. It is hypothesized that it is feasible to deliver the two weight gain prevention interventions among African American breast cancer survivors, and participants in the two intervention groups will have a lower magnitude of weight gain at 6-month follow-up relative to those in the delayed control group.

NCT ID: NCT01933113 Completed - Obesity Clinical Trials

Deep Brain Stimulation Effects on Weight Change and Metabolic Rate

Start date: August 2013
Phase: N/A
Study type: Interventional

This study focuses on lateral hypothalamic area (LHA) deep brain stimulation (DBS) for severe obesity. In a previous pilot study, three subjects were implanted with a DBS electrode into the LHA under an Investigational Device Exemption (IDE) and IRB approved study at West Virginia University. That study demonstrated the safety of DBS of the LHA in these patients. These patients, who met the enrollment criteria of having prior placement of LHA DBS in accordance with previous study protocol, were eligible for this study with a goal of determining optimal DBS settings.